Jul 23, 2025 04:00PM Champions Oncology Reports Record Annual Revenue of $57 Million

Jul 18, 2025 08:31AM Champions Oncology appoints Rob Brainin as new CEO

Jul 18, 2025 08:30AM Champions Oncology Announces Appointment of New CEO

Jul 8, 2025 08:30AM Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models

Apr 28, 2025 09:47AM Champions Oncology (CSBR) Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House

Apr 28, 2025 09:45AM Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House

Apr 24, 2025 08:00AM Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine

Mar 12, 2025 08:37AM Champions Oncology (CSBR) PT Raised to $12 at Craig-Hallum

Mar 11, 2025 04:34PM Champions Oncology (CSBR) Tops Q3 EPS by 37c

Mar 11, 2025 03:55PM Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million

Mar 6, 2025 04:00PM Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025

Feb 18, 2025 09:00AM Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting

Jan 8, 2025 08:03AM Champions Oncology (CSBR) Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership

Jan 8, 2025 08:00AM Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership

Dec 11, 2024 04:41PM Champions Oncology (CSBR) Tops Q2 EPS by 8c

Dec 11, 2024 04:00PM Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million

Dec 5, 2024 04:30PM Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024

Oct 16, 2024 10:57AM Champions Oncology (CSBR) Announces Agreement with Weill Cornell Medicine

Oct 16, 2024 10:55AM Champions Oncology Announces Agreement with Weill Cornell Medicine

Sep 11, 2024 04:00PM Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million

Jul 18, 2024 04:51PM Champions Oncology (CSBR) Tops Q4 EPS by 17c

Jul 18, 2024 04:00PM Champions Oncology Reports Quarterly Revenue of $14.0 Million

Jul 11, 2024 04:05PM Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024